Drug Profile
Research programme: analgesics - Orion
Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Orion
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Neuropathic pain
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for research development in Neuropathic-pain in Finland
- 03 Mar 2011 Research is ongoing in Finland